Cyanotech Stock (OTC:CYAN), Trade Ideas

Cyanotech

Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The company's products include BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. BioAstin Hawaiian Astaxanthin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health. It derives maximum revenue from the Packaged product and geographically from the United States.

Long Ideas

News

Penny Stocks

Small Cap

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

BCOV

CYAN

LUMN

RZLT

The Dow Jones index closed lower by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lumen Technologies And 3 Other Stocks Under $3 Insiders Are Buying

BCAB

CRDF

XAIR

The Dow Jones index closed higher by around 250 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Around $2M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

FTCI

JSDA

The Dow Jones closed lower by around 40 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

FTC Solar And 3 Other Stocks Under $2 Insiders Are Buying

Cyanotech Corp

Cyan AG

The Dow Jones index closed lower by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Brightcove </h3>
<ul>
<li>The Trade: Brightcove Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcov#NASDAQ">BCOV</a>) 10% owner Jonathan Brolin <a href="https://www.benzinga.com/quote/BCOV/analyst-ratings"> acquired a total of 41,747 shares </a> an average price of $1.86. To acquire these shares, it cost around $77,667. The company&rsquo;s CEO also bought 25,000 shares of the company.</li>
<li>What&rsquo;s Happening: On Feb. 22, Brightcove reported fourth-quarter financial results and issued FY24 guidance below estimates..</li>
<li>What Brightcove Does: Brightcove Inc is a provider of cloud-based streaming technology and services.</li>
</ul>
<h3>Lumen Technologies</h3>
<ul>
<li>The Trade: Lumen Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lumn#NYSE">LUMN</a>) Director T Michael Glenn <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 50,000 shares at </a> at an average price of $1.47. To acquire these shares, it cost around $73,300.</li>
<li>What&rsquo;s Happening: On Feb. 6, Lumen Technologies reported better-than-expected fourth-quarter financial results.</li>
<li>What Lumen Technologies Does: With 450,000 route miles of fiber, Lumen Technologies is one of the United States&#39; largest telecommunications carriers serving global enterprises.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/02/37327879/macys-lowes-and-3-stocks-to-watch-heading-into-tuesday"> Macy&#39;s, Lowe&#39;s And 3 Stocks To Watch Heading Into Tuesday </a>
<h3>Rezolute </h3>
<ul>
<li>The Trade: Rezolute, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rzlt#NASDAQ">RZLT</a>) Chief Medical Officer Brian Kenneth Roberts <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 8,000 shares </a> at an average price of $1.69. The insider spent around $13,540 to buy those shares.</li>
<li>What&rsquo;s Happening: On Feb. 13, Rezolute posted a narrower-than-expected second-quarter loss.</li>
<li>What Rezolute Does: Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies.</li>
</ul>
<h3>Cyanotech </h3>
<ul>
<li>The Trade: Cyanotech Corporation (OTC: <a class="ticker" href="https://www.benzinga.com/stock/cyan#OTC">CYAN</a>) VP, Operations Glenn Jensen <a href="https://www.benzinga.com/quote/CYAN/analyst-ratings"> acquired a total of 16,835 shares </a> at an average price of $0.31. The insider spent around $5,222 to buy those shares.</li>
<li>What&rsquo;s Happening: On Feb. 8, Cyanotech posted a wider quarterly loss.</li>
<li>What Cyanotech Does: Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market.</li>
</ul>

Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

<h3>Gainers</h3>
<ul>
<li>Bit Brother (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BETS#NASDAQ">BETS</a>) shares rose 55.4% to $2.77 during Thursday's regular session. The market value of their outstanding shares is at $1.7 million. </li>
<li>Guardion Health Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GHSI#NASDAQ">GHSI</a>) shares increased by 13.94% to $8.5. The market value of their outstanding shares is at $10.8 million. </li>
<li>China Jo-Jo Drugstores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CJJD#NASDAQ">CJJD</a>) shares moved upwards by 12.66% to $0.2. The market value of their outstanding shares is at $6.7 million. </li>
<li>Maison Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSS#NASDAQ">MSS</a>) stock rose 12.26% to $1.1. The company's market cap stands at $21.6 million. </li>
<li>Webuy Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBUY#NASDAQ">WBUY</a>) shares rose 12.2% to $0.5. The company's market cap stands at $26.2 million. </li>
<li>Chanson International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHSN#NASDAQ">CHSN</a>) shares rose 11.84% to $1.7. The company's market cap stands at $21.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) stock declined by 14.0% to $0.62 during Thursday's regular session. The market value of their outstanding shares is at $4.2 million. As per the news, the Q3 earnings report came out today. </li>
<li>Better Choice Co (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BTTR#AMEX">BTTR</a>) shares declined by 13.28% to $0.18. The market value of their outstanding shares is at $5.8 million. </li>
<li>DDC Enterprise (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DDC#AMEX">DDC</a>) stock declined by 11.01% to $1.86. The company's market cap stands at $35.4 million. </li>
<li>MedAvail Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDVL#NASDAQ">MDVL</a>) shares declined by 10.48% to $2.82. The market value of their outstanding shares is at $4.5 million. </li>
<li>Steakholder Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKH#NASDAQ">STKH</a>) shares fell 10.44% to $0.64. The market value of their outstanding shares is at $17.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-defensive-stocks/" title="www.benzinga.com/money/best-consumer-defensive-stocks/">www.benzinga.com/money/best-consumer-defensive-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

BETS

BTTR

CHSN

CJJD

GHSI

MDVL

Merrill Lynch & Strategic Return Notes for Select 10 Index

STKH

WBUY

11 Consumer Staples Stocks Moving In Thursday's Intraday Session

Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) reported quarterly losses of $(0.16) per share. This is a 60 percent decrease over losses of $(0.10) per share from the same period last year. The company reported $5.58 million in sales this quarter. This is a 5.25 percent decrease over sales of $5.89 million the same period last year.

Earnings

Cyanotech Q3 EPS $(0.16) Down From $(0.10) YoY, Sales $5.58M Down From $5.89M YoY

The Dow Jones index closed higher by around 250 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Cyanotech </h3>
<ul>
<li>The Trade: Cyanotech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyan#NASDAQ">CYAN</a>) Director Michael Davis <a href="https://www.benzinga.com/quote/CYAN/analyst-ratings"> acquired a total of 400,000 shares </a> an average price of $1.00. To acquire these shares, it cost around $400,000.</li>
<li>What&rsquo;s Happening: On Nov. 8, Cyanotech posted a narrower loss for the second quarter.</li>
<li>What Cyanotech Does: Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market.</li>
</ul>
<h3>BioAtla</h3>
<ul>
<li>The Trade: BioAtla, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcab#NASDAQ">BCAB</a>) Director Lawrence Steinman <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 20,000 shares </a> at an average price of $2.05. To acquire these shares, it cost around $41,048.</li>
<li>What&rsquo;s Happening: BioAtla, last month, said net loss for the third quarter was $33.3 million, versus a year-ago net loss of $25.8 million.</li>
<li>What BioAtla Does: BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/12/36300408/top-5-industrials-stocks-which-could-rescue-your-portfolio-this-quarter"> Top 5 Industrials Stocks Which Could Rescue Your Portfolio This Quarter </a>
<h3>Beyond Air </h3>
<ul>
<li>The Trade: Beyond Air, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xair#NASDAQ">XAIR</a>) Director Robert Carey <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 1,200,000 shares </a> at an average price of $1.64. The insider spent around $1.96 million to buy those shares. The company&rsquo;s CEO and Chairman of the Board also bought 77,775 shares of the company.</li>
<li>What&rsquo;s Happening: On Nov. 13, Beyond Air posted downbeat quarterly results.</li>
<li>What Beyond Air Does: Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases.</li>
</ul>
<h3>Cardiff Oncology </h3>
<ul>
<li>The Trade: Cardiff Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdf#NASDAQ">CRDF</a>) Director Gary Pace <a href="https://www.benzinga.com/quote/DFCO/analyst-ratings"> acquired a total of 30,000 shares </a> at an average price of $1.37. The insider spent around $41,100 to buy those shares.</li>
<li>What&rsquo;s Happening: On Nov. 2, Cardiff Oncology posted upbeat quarterly results.</li>
<li>What Cardiff Oncology Does: Cardiff Oncology Inc is a clinical-stage, biotechnology company, developing treatment options for cancer patients in indications with the greatest medical need, including KRAS-mutated metastatic colorectal cancer, pancreatic cancer, metastatic castrate-resistant prostate cancer and leukemias.</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

The Dow Jones closed lower by around 40 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>FTC Solar </h3>
<ul>
<li>The Trade: FTC Solar, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftci#NASDAQ">FTCI</a>) Director Ahmad Chatila <a href="https://www.benzinga.com/quote/FTCI/analyst-ratings"> acquired a total of 14,550 shares </a> an average price of $0.68. To acquire these shares, it cost around $9,894.</li>
<li>What&rsquo;s Happening: On Nov. 8, FTC Solar reported mixed third-quarter financial results and issued guidance.</li>
<li>What FTC Solar Does: FTC Solar Inc is a global provider of advanced solar tracker systems, supported by proprietary software and value-added engineering services.</li>
</ul>
<h3>Retractable Technologies</h3>
<ul>
<li>The Trade: Retractable Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rvp#NYSE">RVP</a>) President and CEO Thomas J Shaw <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 1,626 shares </a> at an average price of $1.15. To acquire these shares, it cost around $1,865.</li>
<li>What&rsquo;s Happening: On Nov. 14, Retractable Technologies reported that its loss from operations was $8.7 million for the first nine months of 2023.</li>
<li>What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/23/12/36068219/top-4-financial-stocks-that-may-fall-off-a-cliff-in-q4"> Top 4 Financial Stocks That May Fall Off A Cliff In Q4</a><a href="https://www.benzinga.com/news/earnings/23/12/36063278/saic-hawaiian-holdings-and-3-stocks-to-watch-heading-into-monday"> </a>
<h3>Cyanotech </h3>
<ul>
<li>The Trade: Cyanotech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyan#NASDAQ">CYAN</a>) Director Michael Davis <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 39,455 shares </a> at an average price of $0.90. The insider spent around $35,510 to buy those shares.</li>
<li>What&rsquo;s Happening: On Nov. 8, Cyanotech posted a narrower loss for the second quarter.</li>
<li>What Cyanotech Does: Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market.</li>
</ul>
<h3>Jones Soda </h3>
<ul>
<li>The Trade: Jones Soda Co. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/jsda#OTC">JSDA</a>) Director Gregg Reichman <a href="https://www.benzinga.com/quote/JSDA/analyst-ratings"> acquired a total of 175,200 shares </a> at an average price of $0.15. The insider spent around $26,277 to buy those shares.</li>
<li>What&rsquo;s Happening: On Nov. 9, Jones Soda posted a narrower quarterly loss.</li>
<li>What Jones Soda Does: Jones Soda Co develops, produces, markets and distributes premium beverages which the company sells and distributes in the United States and Canada through its network of independent distributors and directly to its national and regional retail accounts.</li>
</ul>
&nbsp;
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a>

Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) reported quarterly losses of $(0.13) per share. This is a 13.33 percent increase over losses of $(0.15) per share from the same period last year. The company reported $6.37 million in sales this quarter. This is a 23.05 percent increase over sales of $5.18 million the same period last year.

Cyanotech Q2 EPS $(0.13) Up From $(0.15) YoY, Sales $6.37M Up From $5.18M YoY

<h3>Gainers</h3>
<ul>
<li>Meiwu Technology Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNW#NASDAQ">WNW</a>) stock moved upwards by 45.1% to $0.14 during Thursday's regular session. As of 13:31 EST, Meiwu Technology Co's stock is trading at a volume of 108.5 million, which is 23173.3% of its average full-day volume over the last 100 days. The company's market cap stands at $13.9 million. </li>
<li>Better Choice Co (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BTTR#AMEX">BTTR</a>) stock moved upwards by 24.93% to $0.2. Trading volume for Better Choice Co's stock is 53.7 million as of 13:31 EST. This is 5499.9% of its average full-day volume over the last 100 days. The company's market cap stands at $6.4 million. </li>
<li>Planet Green Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PLAG#AMEX">PLAG</a>) shares moved upwards by 12.69% to $0.74. Trading volume for this security as of 13:31 EST is 77.3K, which is 27.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $53.6 million. </li>
<li>Davis Commodities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTCK#NASDAQ">DTCK</a>) shares moved upwards by 12.45% to $3.43. Trading volume for this security as of 13:31 EST is 233.0K, which is 9.7% of its average full-day volume over the last 100 days. The company's market cap stands at $83.4 million. </li>
<li>Splash Beverage Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SBEV#AMEX">SBEV</a>) stock increased by 10.65% to $0.68. The current volume of 128.6K shares is 50.9% of Splash Beverage Group's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $28.9 million. </li>
<li>Lamb Weston Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) stock increased by 9.54% to $99.13. Lamb Weston Hldgs's stock is trading at a volume of 4.6 million shares as of 13:31 EST. This is 290.0% of its average full-day volume over the last 100 days. The company's market cap stands at $14.4 billion. The company's, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Zivo Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZIVO#NASDAQ">ZIVO</a>) shares declined by 22.5% to $1.0 during Thursday's regular session. The current volume of 73.4K shares is 535.7% of Zivo Bioscience's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $10.4 million. </li>
<li>Alkaline Water Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTER#NASDAQ">WTER</a>) shares fell 13.12% to $0.27. Trading volume for Alkaline Water Co's stock is 343.9K as of 13:31 EST. This is 172.1% of its average full-day volume over the last 100 days. The company's market cap stands at $2.9 million. </li>
<li>Safety Shot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOT#NASDAQ">SHOT</a>) shares decreased by 12.41% to $1.09. As of 13:31 EST, this security is trading at a volume of 518.3K shares, making up 69.0% of its average full-day volume over the last 100 days. The company's market cap stands at $35.5 million. </li>
<li>Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) stock decreased by 10.8% to $0.78. The market value of their outstanding shares is at $5.0 million. </li>
<li>Missfresh (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MF#NASDAQ">MF</a>) shares decreased by 8.88% to $0.82. The market value of their outstanding shares is at $6.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-defensive-stocks/" title="www.benzinga.com/money/best-consumer-defensive-stocks/">www.benzinga.com/money/best-consumer-defensive-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

DTCK

PLAG

SBEV

SHOT

WTER

ZIVO

Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) reported quarterly losses of $(0.22) per share. This is a 175 percent decrease over losses of $(0.08) per share from the same period last year. The company reported $5.15 million in sales this quarter. This is a 23.38 percent decrease over sales of $6.72 million the same period last year.

Cyanotech Q1 EPS $(0.22) Down From $(0.08) YoY, Sales $5.15M Down From $6.72M YoY

Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) reported quarterly losses of $(0.23) per share. This is a 675 percent decrease over earnings of $0.04 per share from the same period last year. The company reported $5.39 million in sales this quarter. This is a 33.67 percent decrease over sales of $8.13 million the same period last year.

Cyanotech Q4 EPS $(0.23) Down From $0.04 YoY, Sales $5.39M Down From $8.13M YoY

On June 15, Cyanotech Corp Received Letter From Nasdaq Notifying Co It Has Regained Compliance With Listing Rule 5550(A)(2)

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi"> RSI is below 30.</a>
Here&rsquo;s the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3>Better Choice Company Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bttr#NYSE">BTTR</a>)</h3>
<ul>
<li>Better Choice said Sharla A. Cook has resigned from her role as CFO, Secretary and Treasurer of the company, effective April 3, 2023. The company&rsquo;s stock has a <a href="https://www.benzinga.com/quote/BTTR">52-week low of $0.3247 </a>.</li>
<li>RSI Value: 27.42</li>
<li>BTTR Price Action: Shares of Better Choice Company dropped 7.9% to close at $0.35 on Thursday.</li>
</ul>
<h3>Rite Aid Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rad#NYSE">RAD</a>)</h3>
<ul>
<li>Rite Aid plans to dispense abortion pill mifepristone in a limited number of its pharmacies and will serve customers in person or through mail delivery. The company&rsquo;s <a href="https://www.benzinga.com/quote/RAD"> stock has a 52-week low </a> of $2.1850.</li>
<li>RSI Value: 28.45</li>
<li>RAD Price Action: Shares of Rite Aid dropped 6.3% to close at $2.22 on Thursday.</li>
</ul>
<h3>Vintage Wine Estates, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vwe#NASDAQ">VWE</a>)</h3>
<ul>
<li>Vintage Wine Estates announced the sale of Tenma Vineyard for $11 million in cash. The company&rsquo;s stock has a 52-week <a href="https://www.benzinga.com/quote/VWE"> low of $0.97.</a></li>
<li>RSI Value: 23.60</li>
<li>VWE Price Action: Shares of Vintage Wine Estates fell 5.3% to close at $0.9849 on Thursday.</li>
</ul>
<h3>Veru Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veru#NASDAQ">VERU</a>)</h3>
<ul>
<li>Veru filed for <a href="https://www.benzinga.com/quote/VERU"> mixed shelf </a> of up to $200 million. The company&rsquo;s 52-week low is $1.28.</li>
<li>RSI Value: 18.13</li>
<li>VERU Price Action: Shares of Veru dropped 6.8% to close at $1.31 on Thursday.</li>
</ul>
<h3>Cyanotech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyan#NASDAQ">CYAN</a>)</h3>
<ul>
<li>Cyanotech posted a Q3 loss of $0.10 per share. Cyanotech&rsquo;s President and Chief Executive Officer, Matthew K. Custer, said, &quot;Sales in the third quarter improved by $712,000, or 14%, compared to the second quarter, as we saw modest improvement in consumer movement on both finished goods and bulk sales. However, both of our online finished good sales and our international bulk sales are still not performing to historical levels.&quot; The company <a href="https://www.benzinga.com/quote/CYAN"> has a 52-week low </a> of $0.8751.</li>
<li>RSI Value: 29.76</li>
<li>CYAN Price Action: Shares of Cyanotech fell 3.3% to close at $0.8801 on Thursday.</li>
</ul>
Read More: <a href="https://www.benzinga.com/news/earnings/23/03/31487311/oxford-industries-express-and-3-stocks-to-watch-heading-into-friday"> Oxford Industries, Express And 3 Stocks To Watch Heading Into Friday </a>

VERU

Vintage Wine Estates, Inc. - Common Stock

Top 5 Defensive Stocks That Are Set To Fly

Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) reported quarterly losses of $(0.10) per share. This is a 266.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported $5.89 million in sales this quarter. This is a 37.72 percent decrease over sales of $9.46 million the same period last year.

Cyanotech Q3 EPS $(0.10) Down From $0.06 YoY, Sales $5.89M Down From $9.46M YoY

Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) reported quarterly losses of $(0.15) per share. This is a 200 percent decrease over earnings of $0.15 per share from the same period last year. The company reported $5.18 million in sales this quarter. This is a 45.02 percent decrease over sales of $9.42 million the same period last year.

Cyanotech Q2 EPS $(0.15) Down From $0.15 YoY, Sales $5.18M Down From $9.42M YoY

WIIM

Cyanotech shares are trading lower after the company reported Q1 EPS results were down year over year.

Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) reported quarterly losses of $(0.08) per share. This is a 200 percent decrease over earnings of $0.08 per share from the same period last year.

Cyanotech Q1 EPS $(0.08) Down From $0.08 YoY

Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) reported quarterly earnings of $0.04 per share. This is a 233.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported $8.13 million in sales this quarter. This is a 13.90 percent decrease over sales of $9.44 million the same period last year.

Cyanotech Q4 EPS $0.04 Up From $(0.03) YoY, Sales $8.13M Down From $9.44M YoY

&nbsp;
<h1>&nbsp;</h1>
On Thursday, 89 companies hit new 52-week lows.
<h2>Noteable 52-Week Lows:</h2>
<ul>
<li>The company with the largest market cap to set a new 52-week low was Seagen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGEN#NASDAQ">SGEN</a>).</li>
<li>The smallest company by market cap to set a new 52-week low was GBS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBS#NASDAQ">GBS</a>).</li>
<li>Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) was the biggest loser, trading down 42.67% to reach its 52-week low.</li>
<li>Skillsoft (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKIL#NYSE">SKIL</a>)&#39;s stock made the biggest bounce back, actually moving up 0.0% shortly after hitting a new 52-week low.</li>
</ul>
Here is a list of stocks that set new 52-week lows on Thursday:
<ul>
<li>Seagen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGEN#NASDAQ">SGEN</a>) shares moved down 15.2% on Thursday to hit a new 52-week low of $118.00, drifting down 15.2%.</li>
<li>Lumen Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) shares moved down 15.64% on Thursday to hit a new 52-week low of $10.74, drifting down 15.64%.</li>
<li>AAON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAON#NASDAQ">AAON</a>) stock set a new 52-week low of $58.55 on Thursday, moving down 1.54%.</li>
<li>Canada Goose Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOOS#NYSE">GOOS</a>) shares were down 17.63% for the day, having made a 52-week low of $27.02.</li>
<li>Babylon Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBLN#NYSE">BBLN</a>) shares moved up 0.2% on Thursday to hit a new 52-week low of $4.96, drifting up 0.2%.</li>
<li>Pactiv Evergreen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTVE#NASDAQ">PTVE</a>) stock set a new 52-week low of $10.01 on Thursday, moving down 1.06%.</li>
<li>Vimeo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) shares set a new yearly low of $9.20 this morning. The stock was down 25.87% on the session.</li>
<li>KAR Auction Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAR#NYSE">KAR</a>) stock achieved a new 52-week low on Thursday morning, hitting $12.67 and moving down 1.17%.</li>
<li>Community Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHCT#NYSE">CHCT</a>) stock set a new 52-week low of $42.03 on Thursday, moving down 0.96%.</li>
<li>Flaherty &amp; Crumrine (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FFC#NYSE">FFC</a>) stock hit a yearly low of $19.30. The stock was down 0.71% for the day.</li>
<li>Skillsoft (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKIL#NYSE">SKIL</a>) shares reached a new 52-week low of $6.52 on Thursday morning, moving 0.0% (flat).</li>
<li>Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) stock dropped to a yearly low on Thursday of $13.44. Shares traded down 5.16%.</li>
<li>Invesco Municipal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMO#NYSE">VMO</a>) shares hit a yearly low of $12.14. The stock was 0.0% (flat) on the session.</li>
<li>2U (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWOU#NASDAQ">TWOU</a>) stock dropped to a yearly low on Thursday of $10.21. Shares traded down 41.6%.</li>
<li>Nuveen California (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKX#NYSE">NKX</a>) shares reached a new 52-week low of $14.48 on Thursday morning, moving up 0.03%.</li>
<li>Invesco Municipal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VKQ#NYSE">VKQ</a>) shares set a new yearly low of $11.88 this morning. The stock was down 0.14% on the session.</li>
<li>Blackrock Muniyield Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYD#NYSE">MYD</a>) stock achieved a new 52-week low on Thursday morning, hitting $13.18 and moving up 0.08%.</li>
<li>Diebold Nixdorf (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBD#NYSE">DBD</a>) stock hit a yearly low of $7.54. The stock was down 8.91% for the day.</li>
<li>Cara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares reached a new 52-week low of $10.30 on Thursday morning, moving up 0.57%.</li>
<li>Berkeley Lights (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLI#NASDAQ">BLI</a>) shares moved down 1.67% on Thursday to hit a new 52-week low of $7.81, drifting down 1.67%.</li>
<li>Blackrock Muniyield NY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYN#NYSE">MYN</a>) shares moved down 0.23% on Thursday to hit a new 52-week low of $13.05, drifting down 0.23%.</li>
<li>Eaton Vance Municipal IT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVN#NYSE">EVN</a>) shares moved down 1.19% on Thursday to hit a new 52-week low of $12.41, drifting down 1.19%.</li>
<li>MediaAlpha (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) stock hit $11.53 on Thursday morning, setting a new 52-week low for a change of down 0.41%.</li>
<li>Guggenheim Taxable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBAB#NYSE">GBAB</a>) stock set a new 52-week low of $20.62 on Thursday, moving 0.0% (flat).</li>
<li>Sculptor Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCU#NYSE">SCU</a>) stock achieved a new 52-week low on Thursday morning, hitting $17.20 and moving 0.0% (flat).</li>
<li>Nuveen New York Quality (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NAN#NYSE">NAN</a>) shares were down 0.19% for the day, having made a 52-week low of $13.27.</li>
<li>Trean Insurance Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIG#NASDAQ">TIG</a>) shares moved down 0.89% on Thursday to hit a new 52-week low of $7.16, drifting down 0.89%.</li>
<li>Blackrock Income Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKT#NYSE">BKT</a>) stock hit $5.19 on Thursday morning, setting a new 52-week low for a change of up 0.14%.</li>
<li>Applied Molecular (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMTI#NASDAQ">AMTI</a>) stock hit $7.70 on Thursday morning, setting a new 52-week low for a change of down 3.46%.</li>
<li>Nuveen AMT-Free Municipal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUW#NYSE">NUW</a>) shares made a new 52-week low of $15.58 on Thursday. The stock was up 1.47% for the day.</li>
<li>Nuveen Ohio Quality (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUO#NYSE">NUO</a>) shares set a new yearly low of $14.81 this morning. The stock was up 0.41% on the session.</li>
<li>Neuberger Berman (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NBH#AMEX">NBH</a>) stock hit $13.97 on Thursday morning, setting a new 52-week low for a change of up 0.07%.</li>
<li>Nuveen Select Tax Free (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXP#NYSE">NXP</a>) shares set a new yearly low of $14.95 this morning. The stock was down 0.1% on the session.</li>
<li>InfuSystems Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INFU#AMEX">INFU</a>) stock drifted down 21.57% on Thursday morning to hit a new 52-week low of $10.86.</li>
<li>PIMCO CA Muni Income Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PZC#NYSE">PZC</a>) shares reached a new 52-week low of $9.77 on Thursday morning, moving down 1.01%.</li>
<li>Invesco Bond (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VBF#NYSE">VBF</a>) shares set a new yearly low of $17.98 this morning. The stock was down 0.17% on the session.</li>
<li>U.S. Xpress Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USX#NYSE">USX</a>) shares set a new yearly low of $3.07 this morning. The stock was down 15.38% on the session.</li>
<li>Aeglea BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGLE#NASDAQ">AGLE</a>) stock hit a new 52-week low of $3.41. The stock was down 6.35% on the session.</li>
<li>Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QMCO#NASDAQ">QMCO</a>) shares set a new 52-week low of $2.71. The stock traded down 42.67%.</li>
<li>Nuveen Preferred (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPT#NYSE">JPT</a>) shares fell to $23.21 on Thursday, setting a new 52-week low with a shift of 0.0% (flat).</li>
<li>EMCORE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMKR#NASDAQ">EMKR</a>) shares were down 28.39% for the day, having made a 52-week low of $4.14.</li>
<li>NN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNBR#NASDAQ">NNBR</a>) stock hit a new 52-week low of $3.15. The stock was down 1.22% on the session.</li>
<li>Western Asset Investment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAI#NYSE">PAI</a>) shares set a new 52-week low of $13.86. The stock traded down 0.89%.</li>
<li>Fluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNT#NASDAQ">FLNT</a>) shares fell to $1.34 on Thursday, setting a new 52-week low with a shift of down 0.69%.</li>
<li>Syros Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYRS#NASDAQ">SYRS</a>) stock hit $1.61 on Thursday morning, setting a new 52-week low for a change of down 0.88%.</li>
<li>Surgalign Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRGA#NASDAQ">SRGA</a>) shares reached a new 52-week low of $0.60 on Thursday morning, moving down 1.47%.</li>
<li>Cadiz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDZI#NASDAQ">CDZI</a>) stock set a new 52-week low of $1.95 on Thursday, moving down 4.74%.</li>
<li>Luby&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUB#NYSE">LUB</a>) stock hit $2.77 on Thursday morning, setting a new 52-week low for a change of 0.0% (flat).</li>
<li>PIMCO New York Municipal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNF#NYSE">PNF</a>) stock hit a new 52-week low of $10.58. The stock was down 1.4% on the session.</li>
<li>Avrobio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVRO#NASDAQ">AVRO</a>) stock broke to a new 52-week low of $1.60 on Thursday. Shares of the company traded up 3.03%.</li>
<li>Oncorus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCR#NASDAQ">ONCR</a>) stock hit a yearly low of $2.72. The stock was down 2.56% for the day.</li>
<li>Geospace Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEOS#NASDAQ">GEOS</a>) shares set a new 52-week low of $5.27. The stock traded up 1.12%.</li>
<li>Talis Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLIS#NASDAQ">TLIS</a>) shares made a new 52-week low of $2.17 on Thursday. The stock was down 3.03% for the day.</li>
<li>Predictive Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POAI#NASDAQ">POAI</a>) shares made a new 52-week low of $0.75 on Thursday. The stock was down 1.37% for the day.</li>
<li>Leafly Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFLY#NASDAQ">LFLY</a>) shares made a new 52-week low of $6.11 on Thursday. The stock was down 5.82% for the day.</li>
<li>Mullen Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) stock drifted down 0.53% on Thursday morning to hit a new 52-week low of $1.82.</li>
<li>CSP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSPI#NASDAQ">CSPI</a>) shares set a new 52-week low of $7.75. The stock traded down 1.27%.</li>
<li>RealNetworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNWK#NASDAQ">RNWK</a>) stock drifted down 14.08% on Thursday morning to hit a new 52-week low of $0.70.</li>
<li>Crown ElectroKinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRKN#NASDAQ">CRKN</a>) stock drifted down 7.21% on Thursday morning to hit a new 52-week low of $2.03.</li>
<li>Baosheng Media Group Hldg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) stock broke to a new 52-week low of $0.70 on Thursday. Shares of the company traded down 10.52%.</li>
<li>ENDRA Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDRA#NASDAQ">NDRA</a>) stock hit a new 52-week low of $0.42. The stock was down 13.3% on the session.</li>
<li>Cingulate (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CING#NASDAQ">CING</a>) stock achieved a new 52-week low on Thursday morning, hitting $1.57 and moving up 2.8%.</li>
<li>MIND Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) stock hit a yearly low of $1.27. The stock was down 2.31% for the day.</li>
<li>Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) stock broke to a new 52-week low of $2.66 on Thursday. Shares of the company traded down 5.44%.</li>
<li>Maris Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEK#NASDAQ">MTEK</a>) stock achieved a new 52-week low on Thursday morning, hitting $2.07 and moving down 2.29%.</li>
</ul>
&nbsp;
Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. <a href="https://pro.benzinga.com/?afmc=2a&amp;utm_source=benzinga.com&amp;utm_medium=web&amp;utm_campaign=premium_products">Learn more here</a>.

Options

Intraday Update

AAON

AGLE

AMTI

AVRO

BAOS

BBLN

CARA

CDZI

CHCT

CING

CRKN

CSPI

EMKR

Flaherty Crumrine/Claymore Preferred Securities

FLNC

FLNT

GBAB

GEOS

GOOS

INFU

LFLY

MIND

MTEK

MULN

Blackrock Muniyield New York Quality Fund

Neuberger Berman Intermediate Municipal Fund Inc.

NDRA

Nuveen Insured California Tax-Free Advantage Municipal Fund

NNBR

ONCR

POAI

PTVE

QMCO

RNWK

SGEN

SKIL

SRGA

SYRS

TLIS

TWOU

VMEO

Stocks That Hit 52-Week Lows On Thursday

Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) reported quarterly earnings of $0.06 per share. This is a 53.85 percent decrease over earnings of $0.13 per share from the same period last year. The company reported $9.46 million in sales this quarter. This is a 35.42 percent increase over sales of $6.99 million the same period last year.

Cyanotech Q3 EPS $0.06 Down From $0.13 YoY, Sales $9.46M Up From $6.99M YoY

<h3>Understanding Value Stocks</h3>
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. 
<h2>Benzinga Insights has compiled a list of value stocks in the consumer defensive sector that may be worth watching:</h2>
<ol>
<li>China Online Education Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COE#NYSE">COE</a>) - P/E: 3.96</li>
<li>Seneca Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SENEA#NASDAQ">SENEA</a>) - P/E: 3.93</li>
<li>Cyanotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYAN#NASDAQ">CYAN</a>) - P/E: 9.0</li>
<li>RYB Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYB#NYSE">RYB</a>) - P/E: 8.08</li>
<li>Graham Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHC#NYSE">GHC</a>) - P/E: 6.45</li>
</ol>
This quarter, China Online Education Gr experienced a decrease in earnings per share, which was 0.05 in Q1 and is now -0.13. Seneca Foods has reported Q2 earnings per share at 1.31, which has decreased by 15.48% compared to Q1, which was 1.55. Cyanotech's earnings per share for Q2 sits at 0.15, whereas in Q1, they were at 0.08. RYB Education saw a decrease in earnings per share from 0.23 in Q2 to -0.06 now. Graham Hldgs saw an increase in earnings per share from 3.88 in Q2 to 7.44 now. Most recently, the company reported a dividend yield of 1.0%, which has increased by 0.03% from last quarter's yield of 0.97%.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

SENEA

Overview Of Value Stocks In The Consumer Defensive Sector

When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h2>Outlook Therapeutics </h2>
<ul>
<li>The Trade: Outlook Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/otlk#NASDAQ">OTLK</a>) Director GMS Ventures &amp; Investments <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 16000000 shares </a> at an average price of $1.25. To acquire these shares, it cost $20,000,000.00.</li>
<li>What&rsquo;s Happening: The company recently announced a $10 million bought deal offering of common stock which was afterwards increased to $50 million.</li>
<li>What Outlook Therapeutics Does: Outlook Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.</li>
</ul>
<h2>Destiny Media Technologies </h2>
<ul>
<li>The Trade: Destiny Media Technologies Inc. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/dsny#OTC">DSNY</a>) 10% owner Mark A Graber <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 65042 shares </a> at an average price of $1.15. The insider spent $74,473.09 to buy those shares.</li>
<li>What&rsquo;s Happening: The company&rsquo;s shares have jumped over 55% since the start of the year.</li>
<li>What Destiny Media Technologies Does: Destiny Media Technologies Inc is a provider of secure digital content distribution solutions. The company operates solely in the digital media software segment.</li>
</ul>
<h2>ARC Document Solutions </h2>
<ul>
<li>The Trade: ARC Document Solutions, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/arc#NYSE">ARC</a>) Chairman, President and CEO Kumarakulasingam Suriyakumar <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 57479 shares </a> at an average price of $2.92. To acquire these shares, it cost $168,004.33.</li>
<li>What&rsquo;s Happening: ARC, last month, reported continuing strength in Q3 sales, EPS and EBITDA.</li>
<li>What ARC Document Solutions Does: ARC Document Solutions Inc is a global document solutions provider. The company&#39;s service offerings include managed print services (MPS), offsite services, archive and information management ( AIM), specialized color printing, Web-based document management applications, and equipment and supplies sales.</li>
</ul>
<h2>MultiPlan </h2>
<ul>
<li>The Trade: MultiPlan Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpln#NYSE">MPLN</a>) Executive Vice President and Chief Financial Officer James Head <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 300000 shares </a> at an average price of $4.34. The insider spent $1,302,000.00 to buy those shares.</li>
<li>What&rsquo;s Happening: MultiPlan, last month, named Jim Head as new CFO.</li>
<li>What MultiPlan Does: MultiPlan Corp is committed to helping healthcare payors manage the cost of care, improve their competitiveness, and inspire positive change.</li>
</ul>
<h2>Cyanotech </h2>
<ul>
<li>The Trade: Cyanotech Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cyan#NASDAQ">CYAN</a>) Director Michael Davis <a href="https://www.benzinga.com/sec/insider-trades/"> acquired a total of 36000 shares </a> shares at an average price of $3.51. The insider spent $126,194.40 to buy those shares.</li>
<li>What&rsquo;s Happening: The company, last month, reported a rise in quarterly earnings.</li>
<li>What Cyanotech Does: Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market.</li>
</ul>

DSNY

MPLN

OTLK

5 Penny Stocks Insiders Are Buying

CYANOTECH CORP (CYAN) stock is lower by -64.73% over the last 12 months. InvestorsObserver's proprietary ranking system, gives CYAN stock a score of  8 out of a possible 100. That rank is  influenced by a long-term technical score of 11. CYAN's rank also includes a short-term technical score of 13.  CYAN has an Overall Sco

CYANOTECH CORP (CYAN) Stock  Gains 6.19% This Week: Is It a Good Pick?

Cyanotech GAAP EPS of -$0.55, revenue of $23.18M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start Wednesday with an overview of all the biggest pre-market stock movers traders need to know about this morning!
Moving stocks this morning is a cannabis rally, earnings for the second quarter of 2023, and more.
Let&rsquo;s get into that news below!

<h2>Pre-Market Stock Movers: 10 Top Gainers</h2>
<ol>
<li>Ebet (NASDAQ:<a href="https://investorplace.com/stock-quotes/ebet-stock-quote/">EBET</a>) stock is rocketing more than 77% alongside extremely heavy trading this morning.</li>
<li>180 Life Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/atnf-stock-quote/">ATNF</a>) shares are soaring over 47% as <a href="https://investorplace.com/2023/08/3-reasons-why-investors-are-lighting-up-cannabis-stocks-again/">cannabis stocks start to rally again</a>.</li>
<li>Tango Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/tngx-stock-quote/">TNGX</a>) stock is surging more than 32% with heavy trading this morning.</li>
<li>Akanda (NASDAQ:<a href="https://investorplace.com/stock-quotes/akan-stock-quote/">AKAN</a>) shares are rising over 25% alongside other <a href="https://investorplace.com/industries/healthcare/cannabis/">cannabis stocks</a>.</li>
<li>Esports Entertainment (NASDAQ:<a href="https://investorplace.com/stock-quotes/gmbl-stock-quote/">GMBL</a>) stock is gaining more than 23% without a clear reason this morning.</li>
<li>Marker Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/mrkr-stock-quote/">MRKR</a>) shares are increasing over 17% on Wednesday morning.</li>
<li>Loop Media (NYSEMKT:<a href="https://investorplace.com/stock-quotes/lptv-stock-quote/">LPTV</a>) stock is climbing more than 17% higher after <a href="https://www.nasdaq.com/press-release/loop-media-announces-strategic-alignment-with-microsoft-advertising-2023-08-08">announcing a strategic alignment</a> with Microsoft (NASDAQ:<a href="https://investorplace.com/stock-quotes/msft-stock-quote/">MSFT</a>) advertising.</li>
<li>Oxbridge Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/oxac-stock-quote/">OXAC</a>) shares are getting an over 17% boost after getting <a href="https://finance.yahoo.com/news/jet-ai-oxbridge-acquisition-corp-123000496.html">shareholder approval for a merger</a>.</li>
<li>Celsius (NASDAQ:<a href="https://investorplace.com/stock-quotes/celh-stock-quote/">CELH</a>) stock is jumping more than 17% after <a href="https://www.prnewswire.com/news-releases/celsius-holdings-inc-reports-record-second-quarter-2023-financial-results-301896199.html">beating EPS and revenue estimates</a> in Q2!</li>
<li>Marqeta (NASDAQ:<a href="https://investorplace.com/stock-quotes/mq-stock-quote/">MQ</a>) shares are up over 16% with <a href="https://seekingalpha.com/news/3999621-marqeta-stock-gaps-up-after-q2-revenue-beats-cash-app-contract-extended">Q2 revenue beating estimates</a>!</li>
</ol>
<h2>10 Top Losers</h2>
<ol>
<li>Cyanotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyan-stock-quote/">CYAN</a>) stock is crashing more than 34% without any clear news this morning.</li>
<li>Bruush Oral Care (NASDAQ:<a href="https://investorplace.com/stock-quotes/brsh-stock-quote/">BRSH</a>) shares are plummeting over 30% following a nearly 140% rally yesterday.</li>
<li>Doximity (NYSE:<a href="https://investorplace.com/stock-quotes/docs-stock-quote/">DOCS</a>) stock is diving more than 28% after <a href="https://finance.yahoo.com/news/doximity-announces-fiscal-2024-first-200100020.html">reducing its outlook</a>.</li>
<li>Nxu (NASDAQ:<a href="https://investorplace.com/stock-quotes/nxu-stock-quote/">NXU</a>) shares are tumbling over 26% as a public stock offering <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317664349&amp;type=PDF&amp;symbol=NXU&amp;cdn=ad5c5bfa9d8b57401632126739de6dc8&amp;companyName=Nxu+Inc.&amp;formType=S-1%2FA&amp;formDescription=%5BAmend%5D+General+form+for+registration+of+securities+under+the+Securities+Act+of+1933&amp;dateFiled=2023-08-04">goes into effect</a>.</li>
<li>PubMatic (NASDAQ:<a href="https://investorplace.com/stock-quotes/pubm-stock-quote/">PUBM</a>) stock is taking a more than 22% beating alongside a <a href="https://finance.yahoo.com/news/pubmatic-inc-pubm-reports-q2-213015008.html">mixed earnings report</a>.</li>
<li>Veritone (NASDAQ:<a href="https://investorplace.com/stock-quotes/veri-stock-quote/">VERI</a>) shares are sliding over 20% <a href="https://finance.yahoo.com/news/veritone-inc-veri-reports-q2-234009886.html">after releasing Q2 earnings</a>.</li>
<li>Infinity Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/infi-stock-quote/">INFI</a>) stock is falling more than 19% on Wednesday morning.</li>
<li>Upstart (NASDAQ:<a href="https://investorplace.com/stock-quotes/upst-stock-quote/">UPST</a>) shares are dropping over 19% despite <a href="https://finance.yahoo.com/news/upstart-holdings-inc-upst-q2-230514599.html">beating Q2 EPS and revenue estimates</a>.</li>
<li>Expensify (NASDAQ:<a href="https://investorplace.com/stock-quotes/exfy-stock-quote/">EXFY</a>) stock is decreasing more than 18% with the release of its <a href="https://www.benzinga.com/pressreleases/23/08/b33642473/expensify-announces-q2-2023-results">latest earnings report</a>.</li>
<li>AerSale (NASDAQ:<a href="https://investorplace.com/stock-quotes/asle-stock-quote/">ASLE</a>) shares close out our pre-market stock movers down over 17% with its <a href="https://finance.yahoo.com/news/aersale-corporation-asle-reports-q2-220518213.html">Q2 earnings release</a>.</li>
</ol>
On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
<ul>
<li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT752258">The #1 AI Name for 2023 Could Be About to Ignite This $20.6 Trillion Wealth Shift</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT752256">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
<li>
						<a href="https://investorplace.com/2022/06/this-could-be-the-best-deal-in-the-history-of-independent-investing-research/?cid=MKT638063&amp;eid=MKT752248">The $1 Investment You MUST Take Advantage of Right Now</a>
					</li>
<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT752254">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
</ul>
<div>
<div>
<div></div>
<div></div>
</div>
</div>
The post <a href="https://investorplace.com/2023/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-august-9th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Cyanotech GAAP EPS of -$0.22, revenue of $5.14M

Cyanotech GAAP EPS of -$0.13, revenue of $6.37M

Cyanotech GAAP EPS of -$0.16, revenue of $5.58M

Cyanotech Corporation (CYAN) Q3 2024 Earnings Call Transcript

Cyanotech Corp. (CYAN) has released an update. Cyanotech Corporation is facing delisting from Nasdaq after its stock price remained below the $1.00...

Cyanotech Corp. Faces Nasdaq Delisting Over Stock Price

AKAN

ASLE

ATNF

BRSH

CELH

DOCS

EBET

EXFY

GMBL

INFI

LPTV

MRKR

MSFT

OXAC

PUBM

TNGX

UPST

VERI

Press Releases

Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2023

Cyanotech Corporation Positions for Accelerated Global Growth in Microalgae Market with Key Leadership Appointment

Cyanotech Reports Financial Results for the First Quarter of Fiscal 2024

Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2024

Cyanotech Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2024

Nutrex-Hawaii Introduces Its #1 Selling BioAstin® Hawaiian Astaxanthin® in a Retail-Ready, Sugar-Free, Vegan Gummy Format